ID   M3K21_HUMAN             Reviewed;        1036 AA.
AC   Q5TCX8; A0A1W2PKR9; B2RN34; Q5TCX7; Q5TCX9; Q8WWN1; Q8WWN2; Q96JM1; X6R610;
DT   19-JUL-2005, integrated into UniProtKB/Swiss-Prot.
DT   28-MAR-2018, sequence version 3.
DT   12-OCT-2022, entry version 165.
DE   RecName: Full=Mitogen-activated protein kinase kinase kinase 21;
DE            EC=2.7.11.25;
DE   AltName: Full=Mitogen-activated protein kinase kinase kinase MLK4;
DE   AltName: Full=Mixed lineage kinase 4;
GN   Name=MAP3K21 {ECO:0000312|HGNC:HGNC:29798};
GN   Synonyms=KIAA1804 {ECO:0000312|EMBL:BAB47433.1}, MLK4
GN   {ECO:0000303|Ref.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:CAC84640.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Heart {ECO:0000312|EMBL:CAC84639.1};
RA   Kvasha S., Protopopov A., Rynditch A., Zabarovsky E., Kashuba V.;
RT   "MLK4, a new member of mixed lineage kinases.";
RL   Submitted (APR-2001) to the EMBL/GenBank/DDBJ databases.
RN   [2] {ECO:0000305, ECO:0000312|EMBL:BAB47433.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Brain {ECO:0000312|EMBL:BAB47433.1};
RX   PubMed=11347906; DOI=10.1093/dnares/8.2.85;
RA   Nagase T., Nakayama M., Nakajima D., Kikuno R., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XX. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 8:85-95(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4] {ECO:0000305, ECO:0000312|EMBL:CAC84640.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-528, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-614, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-528; THR-592 AND SER-614, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-528, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [11]
RP   FUNCTION, AND INTERACTION WITH TLR4.
RX   PubMed=21602844; DOI=10.1038/cmi.2011.15;
RA   Seit-Nebi A., Cheng W., Xu H., Han J.;
RT   "MLK4 has negative effect on TLR4 signaling.";
RL   Cell. Mol. Immunol. 9:27-33(2012).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-528 AND SER-614, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13]
RP   VARIANTS [LARGE SCALE ANALYSIS] ASN-420; ASP-563; PHE-597; ILE-728;
RP   ASP-741; GLY-784; TRP-892; ILE-900; CYS-977 AND LEU-982.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Negative regulator of TLR4 signaling. Does not activate
CC       JNK1/MAPK8 pathway, p38/MAPK14, nor ERK2/MAPK1 pathways.
CC       {ECO:0000269|PubMed:21602844}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.25;
CC         Evidence={ECO:0000305};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.25; Evidence={ECO:0000305};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:P80192};
CC   -!- ACTIVITY REGULATION: Homodimerization via the leucine zipper domains is
CC       required for autophosphorylation and subsequent activation.
CC       {ECO:0000250|UniProtKB:Q16584}.
CC   -!- SUBUNIT: Homodimer (By similarity). Interacts with TLR4. {ECO:0000250,
CC       ECO:0000269|PubMed:21602844}.
CC   -!- INTERACTION:
CC       Q5TCX8; O15111: CHUK; NbExp=2; IntAct=EBI-1057380, EBI-81249;
CC       Q5TCX8; Q02779: MAP3K10; NbExp=3; IntAct=EBI-1057380, EBI-3392815;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1 {ECO:0000269|Ref.1}; Synonyms=MLK4beta;
CC         IsoId=Q5TCX8-1; Sequence=Displayed;
CC       Name=2 {ECO:0000269|Ref.1}; Synonyms=MLK4alpha;
CC         IsoId=Q5TCX8-2; Sequence=VSP_051733, VSP_051734;
CC       Name=3;
CC         IsoId=Q5TCX8-3; Sequence=VSP_051731, VSP_051732;
CC   -!- PTM: Autophosphorylation on serine and threonine residues within the
CC       activation loop plays a role in enzyme activation.
CC       {ECO:0000250|UniProtKB:Q16584}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. MAP kinase kinase kinase subfamily.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB47433.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ311797; CAC84639.1; -; mRNA.
DR   EMBL; AJ311798; CAC84640.1; -; mRNA.
DR   EMBL; AB058707; BAB47433.1; ALT_INIT; mRNA.
DR   EMBL; AL133380; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471098; EAW69988.1; -; Genomic_DNA.
DR   EMBL; BC136648; AAI36649.1; -; mRNA.
DR   EMBL; BC136649; AAI36650.1; -; mRNA.
DR   CCDS; CCDS1598.1; -. [Q5TCX8-1]
DR   RefSeq; NP_115811.2; NM_032435.2. [Q5TCX8-1]
DR   PDB; 4UYA; X-ray; 2.80 A; A=115-451.
DR   PDBsum; 4UYA; -.
DR   AlphaFoldDB; Q5TCX8; -.
DR   SMR; Q5TCX8; -.
DR   BioGRID; 124089; 105.
DR   IntAct; Q5TCX8; 33.
DR   STRING; 9606.ENSP00000355583; -.
DR   BindingDB; Q5TCX8; -.
DR   ChEMBL; CHEMBL3627584; -.
DR   iPTMnet; Q5TCX8; -.
DR   PhosphoSitePlus; Q5TCX8; -.
DR   BioMuta; MAP3K21; -.
DR   DMDM; 71153820; -.
DR   EPD; Q5TCX8; -.
DR   jPOST; Q5TCX8; -.
DR   MassIVE; Q5TCX8; -.
DR   MaxQB; Q5TCX8; -.
DR   PaxDb; Q5TCX8; -.
DR   PeptideAtlas; Q5TCX8; -.
DR   PRIDE; Q5TCX8; -.
DR   ProteomicsDB; 64992; -. [Q5TCX8-1]
DR   ProteomicsDB; 64993; -. [Q5TCX8-2]
DR   ProteomicsDB; 64994; -. [Q5TCX8-3]
DR   Antibodypedia; 2080; 229 antibodies from 29 providers.
DR   DNASU; 84451; -.
DR   Ensembl; ENST00000366622.1; ENSP00000355581.1; ENSG00000143674.11. [Q5TCX8-3]
DR   Ensembl; ENST00000366623.7; ENSP00000355582.3; ENSG00000143674.11. [Q5TCX8-2]
DR   Ensembl; ENST00000366624.8; ENSP00000355583.3; ENSG00000143674.11. [Q5TCX8-1]
DR   GeneID; 84451; -.
DR   KEGG; hsa:84451; -.
DR   MANE-Select; ENST00000366624.8; ENSP00000355583.3; NM_032435.3; NP_115811.2.
DR   UCSC; uc001hvt.4; human. [Q5TCX8-1]
DR   CTD; 84451; -.
DR   DisGeNET; 84451; -.
DR   GeneCards; MAP3K21; -.
DR   HGNC; HGNC:29798; MAP3K21.
DR   HPA; ENSG00000143674; Tissue enhanced (pancreas).
DR   MIM; 614793; gene.
DR   neXtProt; NX_Q5TCX8; -.
DR   OpenTargets; ENSG00000143674; -.
DR   VEuPathDB; HostDB:ENSG00000143674; -.
DR   eggNOG; KOG0192; Eukaryota.
DR   GeneTree; ENSGT00940000159629; -.
DR   InParanoid; Q5TCX8; -.
DR   OMA; DPEMPTP; -.
DR   OrthoDB; 115270at2759; -.
DR   PhylomeDB; Q5TCX8; -.
DR   BRENDA; 2.7.11.25; 2681.
DR   PathwayCommons; Q5TCX8; -.
DR   SignaLink; Q5TCX8; -.
DR   SIGNOR; Q5TCX8; -.
DR   BioGRID-ORCS; 84451; 13 hits in 1060 CRISPR screens.
DR   ChiTaRS; MAP3K21; human.
DR   GenomeRNAi; 84451; -.
DR   Pharos; Q5TCX8; Tbio.
DR   PRO; PR:Q5TCX8; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q5TCX8; protein.
DR   Bgee; ENSG00000143674; Expressed in kidney epithelium and 128 other tissues.
DR   Genevisible; Q5TCX8; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004706; F:JUN kinase kinase kinase activity; ISS:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; ISS:UniProtKB.
DR   GO; GO:0004672; F:protein kinase activity; IBA:GO_Central.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0046777; P:protein autophosphorylation; ISS:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; ISS:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; IBA:GO_Central.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR016231; MLK1-4.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   Pfam; PF07714; PK_Tyr_Ser-Thr; 1.
DR   Pfam; PF14604; SH3_9; 1.
DR   PIRSF; PIRSF000556; MAPKKK9_11; 1.
DR   PRINTS; PR00452; SH3DOMAIN.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00220; S_TKc; 1.
DR   SMART; SM00326; SH3; 1.
DR   SUPFAM; SSF50044; SSF50044; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS50002; SH3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Kinase;
KW   Nucleotide-binding; Phosphoprotein; Reference proteome; Repeat;
KW   Serine/threonine-protein kinase; SH3 domain; Transferase.
FT   CHAIN           1..1036
FT                   /note="Mitogen-activated protein kinase kinase kinase 21"
FT                   /id="PRO_0000086268"
FT   DOMAIN          38..102
FT                   /note="SH3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   DOMAIN          124..401
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          1..36
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          425..446
FT                   /note="Leucine-zipper 1"
FT   REGION          460..481
FT                   /note="Leucine-zipper 2"
FT   REGION          517..551
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          748..791
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          923..954
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        17..36
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        519..549
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        748..767
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        768..791
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        263
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:Q02779,
FT                   ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-
FT                   ProRule:PRU10027"
FT   BINDING         130..138
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q02779,
FT                   ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         151
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q02779,
FT                   ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         299
FT                   /note="Phosphothreonine; by autocatalysis"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         303
FT                   /note="Phosphoserine; by autocatalysis and MAP4K1"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         528
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18691976,
FT                   ECO:0007744|PubMed:19369195, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         543
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VDG6"
FT   MOD_RES         547
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VDG6"
FT   MOD_RES         592
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:19369195"
FT   MOD_RES         614
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19369195, ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         1..554
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:11347906"
FT                   /id="VSP_051731"
FT   VAR_SEQ         555..559
FT                   /note="RAIQL -> MFFLV (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:11347906"
FT                   /id="VSP_051732"
FT   VAR_SEQ         559..570
FT                   /note="LTSDESNKTWGR -> CELSALPRGLLC (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.1"
FT                   /id="VSP_051733"
FT   VAR_SEQ         571..1036
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.1"
FT                   /id="VSP_051734"
FT   VARIANT         420
FT                   /note="D -> N (in dbSNP:rs35465006)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040729"
FT   VARIANT         563
FT                   /note="E -> D (in dbSNP:rs35758282)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040730"
FT   VARIANT         597
FT                   /note="S -> F (in dbSNP:rs34984140)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040731"
FT   VARIANT         728
FT                   /note="V -> I (in dbSNP:rs3795375)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040732"
FT   VARIANT         741
FT                   /note="E -> D (in dbSNP:rs3795374)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040733"
FT   VARIANT         784
FT                   /note="C -> G (in dbSNP:rs963981)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040734"
FT   VARIANT         892
FT                   /note="R -> W (in dbSNP:rs55681416)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040735"
FT   VARIANT         900
FT                   /note="T -> I (in dbSNP:rs34499091)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040736"
FT   VARIANT         977
FT                   /note="R -> C (in dbSNP:rs56065162)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040737"
FT   VARIANT         982
FT                   /note="P -> L (in dbSNP:rs34794284)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040738"
FT   CONFLICT        274
FT                   /note="K -> E (in Ref. 1; CAC84639/CAC84640)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        330
FT                   /note="Y -> C (in Ref. 1; CAC84639/CAC84640)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        687
FT                   /note="E -> G (in Ref. 1; CAC84640)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        701
FT                   /note="S -> T (in Ref. 1; CAC84640)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        705
FT                   /note="T -> A (in Ref. 1; CAC84640)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        781
FT                   /note="P -> S (in Ref. 1; CAC84640)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        872
FT                   /note="Q -> R (in Ref. 1; CAC84640)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1002
FT                   /note="A -> V (in Ref. 1; CAC84640)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1016
FT                   /note="C -> G (in Ref. 1; CAC84640)"
FT                   /evidence="ECO:0000305"
FT   HELIX           121..123
FT                   /evidence="ECO:0007829|PDB:4UYA"
FT   STRAND          125..129
FT                   /evidence="ECO:0007829|PDB:4UYA"
FT   STRAND          138..143
FT                   /evidence="ECO:0007829|PDB:4UYA"
FT   STRAND          146..152
FT                   /evidence="ECO:0007829|PDB:4UYA"
FT   HELIX           165..175
FT                   /evidence="ECO:0007829|PDB:4UYA"
FT   STRAND          186..190
FT                   /evidence="ECO:0007829|PDB:4UYA"
FT   STRAND          197..201
FT                   /evidence="ECO:0007829|PDB:4UYA"
FT   HELIX           208..212
FT                   /evidence="ECO:0007829|PDB:4UYA"
FT   HELIX           234..252
FT                   /evidence="ECO:0007829|PDB:4UYA"
FT   STRAND          255..257
FT                   /evidence="ECO:0007829|PDB:4UYA"
FT   HELIX           266..268
FT                   /evidence="ECO:0007829|PDB:4UYA"
FT   STRAND          269..273
FT                   /evidence="ECO:0007829|PDB:4UYA"
FT   STRAND          285..287
FT                   /evidence="ECO:0007829|PDB:4UYA"
FT   HELIX           313..316
FT                   /evidence="ECO:0007829|PDB:4UYA"
FT   HELIX           323..339
FT                   /evidence="ECO:0007829|PDB:4UYA"
FT   TURN            343..346
FT                   /evidence="ECO:0007829|PDB:4UYA"
FT   HELIX           349..357
FT                   /evidence="ECO:0007829|PDB:4UYA"
FT   HELIX           373..380
FT                   /evidence="ECO:0007829|PDB:4UYA"
FT   HELIX           391..399
FT                   /evidence="ECO:0007829|PDB:4UYA"
FT   HELIX           411..436
FT                   /evidence="ECO:0007829|PDB:4UYA"
FT   CONFLICT        Q5TCX8-2:566
FT                   /note="R -> P (in Ref. 1; CAC84639)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1036 AA;  113957 MW;  2520984802143069 CRC64;
     MALRGAAGAT DTPVSSAGGA PGGSASSSST SSGGSASAGA GLWAALYDYE ARGEDELSLR
     RGQLVEVLSQ DAAVSGDEGW WAGQVQRRLG IFPANYVAPC RPAASPAPPP SRPSSPVHVA
     FERLELKELI GAGGFGQVYR ATWQGQEVAV KAARQDPEQD AAAAAESVRR EARLFAMLRH
     PNIIELRGVC LQQPHLCLVL EFARGGALNR ALAAANAAPD PRAPGPRRAR RIPPHVLVNW
     AVQIARGMLY LHEEAFVPIL HRDLKSSNIL LLEKIEHDDI CNKTLKITDF GLAREWHRTT
     KMSTAGTYAW MAPEVIKSSL FSKGSDIWSY GVLLWELLTG EVPYRGIDGL AVAYGVAVNK
     LTLPIPSTCP EPFAKLMKEC WQQDPHIRPS FALILEQLTA IEGAVMTEMP QESFHSMQDD
     WKLEIQQMFD ELRTKEKELR SREEELTRAA LQQKSQEELL KRREQQLAER EIDVLERELN
     ILIFQLNQEK PKVKKRKGKF KRSRLKLKDG HRISLPSDFQ HKITVQASPN LDKRRSLNSS
     SSSPPSSPTM MPRLRAIQLT SDESNKTWGR NTVFRQEEFE DVKRNFKKKG CTWGPNSIQM
     KDRTDCKERI RPLSDGNSPW STILIKNQKT MPLASLFVDQ PGSCEEPKLS PDGLEHRKPK
     QIKLPSQAYI DLPLGKDAQR ENPAEAESWE EAASANAATV SIEMTPTNSL SRSPQRKKTE
     SALYGCTVLL ASVALGLDLR ELHKAQAAEE PLPKEEKKKR EGIFQRASKS RRSASPPTSL
     PSTCGEASSP PSLPLSSALG ILSTPSFSTK CLLQMDSEDP LVDSAPVTCD SEMLTPDFCP
     TAPGSGREPA LMPRLDTDCS VSRNLPSSFL QQTCGNVPYC ASSKHRPSHH RRTMSDGNPT
     PTGATIISAT GASALPLCPS PAPHSHLPRE VSPKKHSTVH IVPQRRPASL RSRSDLPQAY
     PQTAVSQLAQ TACVVGRPGP HPTQFLAAKE RTKSHVPSLL DADVEGQSRD YTVPLCRMRS
     KTSRPSIYEL EKEFLS
//
